Vaping Illnesses: Consumers can Help Protect Themselves by Avoiding Tetrahydrocannabinol (THC)-Containing Vaping Products
- Consumers are likely aware of the recent reports of respiratory illnesses — including some resulting in deaths – following the use of vaping products
- FDA remains deeply concerned about these incidents and is working closely with CDC, state and local public health partners to investigate
- More information needed to better understand whether there’s relationship between specific products or substances and reported illnesses
- CDC and the FDA encourage the public to submit detailed reports of any unexpected tobacco- or e-cigarette-related health or product issues to the FDA via the online Safety Reporting Portal.
image credit: FDA